CANCER-ASSOCIATED IMMUNOSUPPRESSION INHIBITOR

• 收藏
• 分享

专利权人:

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);UNIVERSITE PARIS DESCARTES;GAMAMABS PHARMA

发明人:

Jean-Marc BARRET,Jean-François PROST,Mehdi LAHMAR,Stéphane DEGOVE,Houcine BOUGHERARA,Emmanuel DONNADIEU

申请号：

US16617136

公开号：

US20200148777A1

申请日:

2018.05.29

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to a glyco-engineered Fc fragment-bearing compound for its use as an immunosuppression inhibitor in the treatment of a cancer-associated immunosuppression. The invention further relates to a pharmaceutical composition comprising at least this glyco-engineered Fc fragment-bearing compound.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/